Vext Science Inc (VV5) - Total Assets
Based on the latest financial reports, Vext Science Inc (VV5) holds total assets worth €128.09 Million EUR (≈ $149.75 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Vext Science Inc - Total Assets Trend (2017–2024)
This chart illustrates how Vext Science Inc's total assets have evolved over time, based on quarterly financial data. Also see Vext Science Inc market capitalisation for the company's overall valuation and market capitalisation.
Vext Science Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Vext Science Inc's total assets of €128.09 Million consist of 19.3% current assets and 80.7% non-current assets. Review how much debt does Vext Science Inc carry to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 3.4% |
| Accounts Receivable | €990.10K | 0.7% |
| Inventory | €13.32 Million | 9.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €64.26 Million | 46.9% |
| Goodwill | €5.14 Million | 3.8% |
Asset Composition Trend (2017–2024)
This chart illustrates how Vext Science Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for Vext Science Inc for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Vext Science Inc's current assets represent 19.3% of total assets in 2024, a decrease from 68.8% in 2017.
- Cash Position: Cash and equivalents constituted 3.4% of total assets in 2024, up from 0.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 49.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is intangible assets at 46.9% of total assets.
Vext Science Inc Competitors by Total Assets
Key competitors of Vext Science Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Yunnan Baiyao Group Co Ltd
SHE:000538
|
China | CN¥53.34 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
|
Jiuzhitang Co Ltd
SHE:000989
|
China | CN¥5.73 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
Vext Science Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.95 | 1.65 | 2.72 |
| Quick Ratio | 0.39 | 0.82 | 2.62 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-944.00K | €11.22 Million | €15.17 Million |
Vext Science Inc - Advanced Valuation Insights
This section examines the relationship between Vext Science Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.87 |
| Latest Market Cap to Assets Ratio | 0.24 |
| Asset Growth Rate (YoY) | -8.4% |
| Total Assets | €136.97 Million |
| Market Capitalization | $32.36 Million USD |
Valuation Analysis
Below Book Valuation: The market values Vext Science Inc's assets below their book value (0.24x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Vext Science Inc's assets decreased by 8.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Vext Science Inc (2017–2024)
The table below shows the annual total assets of Vext Science Inc from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €136.97 Million ≈ $160.13 Million |
-8.42% |
| 2023-12-31 | €149.56 Million ≈ $174.85 Million |
+24.10% |
| 2022-12-31 | €120.52 Million ≈ $140.90 Million |
+43.98% |
| 2021-12-31 | €83.70 Million ≈ $97.86 Million |
+50.94% |
| 2020-12-31 | €55.45 Million ≈ $64.83 Million |
+43.00% |
| 2019-12-31 | €38.78 Million ≈ $45.34 Million |
+65.49% |
| 2018-12-31 | €23.43 Million ≈ $27.40 Million |
+69.31% |
| 2017-12-31 | €13.84 Million ≈ $16.18 Million |
-- |
About Vext Science Inc
Vext Science, Inc., through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. The company al… Read more